Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2012

01-02-2012 | Original Article

African Americans with Barrett’s Esophagus Are Less Likely to Have Dysplasia at Biopsy

Authors: Joe E. Khoury, Sian Chisholm, M. Mazen Jamal, Carlos Palacio, Sunitha Pudhota, Kenneth J. Vega

Published in: Digestive Diseases and Sciences | Issue 2/2012

Login to get access

Abstract

Background

Barrett’s Esophagus (BE) is a pre-malignant condition. Limited data on BE dysplasia prevalence exists among United States ethnic groups.

Aim

The purpose of this study was to determine if the frequency of BE with dysplasia varies among the major ethnic groups presenting to our institution.

Methods

The University of Florida-Jacksonville endoscopy database was searched for all cases of endoscopic BE from September 2002 to August 2007. Histologic BE was diagnosed if salmon colored esophageal mucosa was endoscopically seen at least 1 cm above the top of the gastric folds and biopsy revealed intestinal metaplasia with Alcian blue-containing goblet cells. Demographic data collected for all included: age at diagnosis, ethnicity, sex, previous history of esophageal reflux, atypical manifestations (chronic cough, aspiration), endoscopic length of BE, presence or absence of hiatal hernia, esophageal stricture or ulcer, and presence or absence of dysplasia.

Results

Salmon colored esophageal mucosa was observed in 405 of 7,308 patients (5.5%) and histologically confirmed in 115 of 405 patients (28%) reflecting an overall prevalence of BE of 115/7308 (1.6%) in this cohort. Ethnic distribution of histologic BE patients was as follows: 95 (83%) non-Hispanic white (nHw), 16 (14%) African American (AA) and 4 (3%) other. Long segment BE (LSBE) and any form of dysplasia was observed less frequently in AA than nHw (LSBE: 12% vs. 26% and dysplasia: 0% vs. 7%).

Conclusions

LSBE and dysplasia are less frequent in AA than nHw. Studies in AA with BE may illustrate factors limiting dysplasia and LSBE risk.
Literature
1.
go back to reference El-Serag HB, Mason AC, Petersen N, et al. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut. 2002;50:368–372.PubMedCrossRef El-Serag HB, Mason AC, Petersen N, et al. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut. 2002;50:368–372.PubMedCrossRef
2.
go back to reference Kubo A, Corley DA. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol. 2004;99:582–588.PubMedCrossRef Kubo A, Corley DA. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol. 2004;99:582–588.PubMedCrossRef
3.
go back to reference Cook MB, Wild CP, Forman D. A systematic review and meta-analysis of the sex ratio for Barrett’s esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol. 2005;162:1050–1061.PubMedCrossRef Cook MB, Wild CP, Forman D. A systematic review and meta-analysis of the sex ratio for Barrett’s esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol. 2005;162:1050–1061.PubMedCrossRef
4.
go back to reference Shaheen NJ. Advances in Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterology. 2005;128:1554–1566.PubMedCrossRef Shaheen NJ. Advances in Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterology. 2005;128:1554–1566.PubMedCrossRef
5.
go back to reference Conio M, Blanchi S, Lapertosa G, et al. Long-term endoscopic surveillance of patients with Barrett’s esophagus: incidence of dysplasia and adenocarcinoma—a prospective study. Am J Gastroenterol. 2003;98:1931–1939.PubMedCrossRef Conio M, Blanchi S, Lapertosa G, et al. Long-term endoscopic surveillance of patients with Barrett’s esophagus: incidence of dysplasia and adenocarcinoma—a prospective study. Am J Gastroenterol. 2003;98:1931–1939.PubMedCrossRef
6.
go back to reference Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825–1831.PubMedCrossRef Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825–1831.PubMedCrossRef
7.
go back to reference Wong A, Fitzgerald RC. Epidemiologic risk factors for Barrett’s esophagus and associated adenocarcinoma. Clin Gastroenterol Hepatol. 2005;3:1–10.PubMedCrossRef Wong A, Fitzgerald RC. Epidemiologic risk factors for Barrett’s esophagus and associated adenocarcinoma. Clin Gastroenterol Hepatol. 2005;3:1–10.PubMedCrossRef
8.
go back to reference Lieberman D, Fennerty MB, Morris CD, et al. Endoscopic evaluation of patients with dyspepsia: results from the national endoscopic data repository. Gastroenterology. 2004;127:1067–1075.PubMedCrossRef Lieberman D, Fennerty MB, Morris CD, et al. Endoscopic evaluation of patients with dyspepsia: results from the national endoscopic data repository. Gastroenterology. 2004;127:1067–1075.PubMedCrossRef
9.
go back to reference Chalasani N, Wo JM, Hunter JG, et al. Significance of intestinal metaplasia in different areas of esophagus including esophagogastric junction. Dig Dis Sci. 1997;43:603–607.CrossRef Chalasani N, Wo JM, Hunter JG, et al. Significance of intestinal metaplasia in different areas of esophagus including esophagogastric junction. Dig Dis Sci. 1997;43:603–607.CrossRef
10.
go back to reference Spechler SJ, Jain SK, Tendler DA, et al. Racial differences in the frequency of symptoms and complications of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2002;16:1795–1800.PubMedCrossRef Spechler SJ, Jain SK, Tendler DA, et al. Racial differences in the frequency of symptoms and complications of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2002;16:1795–1800.PubMedCrossRef
11.
go back to reference Fisher D, Jeffreys A, Bosworth H, et al. Quality of life in patients with Barrett’s esophagus undergoing surveillance. Am J Gastroenterol. 2002;97:2193–2200.PubMedCrossRef Fisher D, Jeffreys A, Bosworth H, et al. Quality of life in patients with Barrett’s esophagus undergoing surveillance. Am J Gastroenterol. 2002;97:2193–2200.PubMedCrossRef
12.
go back to reference Weston AP, Sharma P, Mathur S, et al. Risk stratification of Barrett’s esophagus: updated prospective multivariate analysis. Am J Gastroenterol. 2004;99:1657–1666.PubMedCrossRef Weston AP, Sharma P, Mathur S, et al. Risk stratification of Barrett’s esophagus: updated prospective multivariate analysis. Am J Gastroenterol. 2004;99:1657–1666.PubMedCrossRef
13.
go back to reference Sharma P, Falk GW, Weston AP, et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2006;4:566–572.PubMedCrossRef Sharma P, Falk GW, Weston AP, et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2006;4:566–572.PubMedCrossRef
14.
go back to reference Abrams JA, Fields S, Lightdale CJ, et al. Racial and ethnic disparities in the prevalence of Barrett’s esophagus among patients who undergo upper endoscopy. Clin Gastroenterol Hepatol. 2008;6:30–34.PubMedCrossRef Abrams JA, Fields S, Lightdale CJ, et al. Racial and ethnic disparities in the prevalence of Barrett’s esophagus among patients who undergo upper endoscopy. Clin Gastroenterol Hepatol. 2008;6:30–34.PubMedCrossRef
15.
go back to reference Fan X, Snyder N. Prevalence of Barrett’s esophagus in patients with or without GERD symptoms: role of race age and gender. Dig Dis Sci. 2009;54:572–577.PubMedCrossRef Fan X, Snyder N. Prevalence of Barrett’s esophagus in patients with or without GERD symptoms: role of race age and gender. Dig Dis Sci. 2009;54:572–577.PubMedCrossRef
16.
go back to reference Wang A, Mattek NC, Holub JL, et al. Prevalence of complicated gastroesophageal reflux disease and Barrett’s esophagus among racial groups in a multicenter consortium. Dig Dis Sci. 2009;54:964–971.PubMedCrossRef Wang A, Mattek NC, Holub JL, et al. Prevalence of complicated gastroesophageal reflux disease and Barrett’s esophagus among racial groups in a multicenter consortium. Dig Dis Sci. 2009;54:964–971.PubMedCrossRef
17.
go back to reference El-Serag HB, Petersen NJ, Carter J, et al. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004;124:1692–1699.CrossRef El-Serag HB, Petersen NJ, Carter J, et al. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004;124:1692–1699.CrossRef
18.
go back to reference Moreno Elola-Olaso C, Rey E, Rodriguez-Artalejo F, et al. Adaptation and validation of a gastroesophageal reflux questionnaire for use in a Spanish population. Rev Esp Enferm Dig. 2002;94:752–758. Moreno Elola-Olaso C, Rey E, Rodriguez-Artalejo F, et al. Adaptation and validation of a gastroesophageal reflux questionnaire for use in a Spanish population. Rev Esp Enferm Dig. 2002;94:752–758.
19.
go back to reference Johnson RL, Roter D, Powe NR, et al. Patient race/ethnicity and quality of patient–physician communication during medical visits. Am J Public Health. 2004;94:2084–2090.PubMedCrossRef Johnson RL, Roter D, Powe NR, et al. Patient race/ethnicity and quality of patient–physician communication during medical visits. Am J Public Health. 2004;94:2084–2090.PubMedCrossRef
20.
go back to reference Vega KJ, Chisholm S, Jamal MM. Comparison of reflux esophagitis and its complications between African Americans and non-Hispanic whites. World J Gastroenterol. 2009;15:2878–2881.PubMedCrossRef Vega KJ, Chisholm S, Jamal MM. Comparison of reflux esophagitis and its complications between African Americans and non-Hispanic whites. World J Gastroenterol. 2009;15:2878–2881.PubMedCrossRef
21.
go back to reference Weston AP, Badr AS, Topalovski M, et al. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett’s esophagus, Barrett’s dysplasia, and Barrett’s adenocarcinoma. Am J Gastroenterol. 2000;95:387–394.PubMedCrossRef Weston AP, Badr AS, Topalovski M, et al. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett’s esophagus, Barrett’s dysplasia, and Barrett’s adenocarcinoma. Am J Gastroenterol. 2000;95:387–394.PubMedCrossRef
22.
go back to reference Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology. 1998;115:50–57.PubMedCrossRef Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology. 1998;115:50–57.PubMedCrossRef
23.
go back to reference Malaty HM, Evans DG, Evans DJ Jr, et al. Helicobacter pylori in Hispanics: comparison with blacks and whites of similar age and socioeconomic class. Gastroenterology. 1992;103:813–816.PubMed Malaty HM, Evans DG, Evans DJ Jr, et al. Helicobacter pylori in Hispanics: comparison with blacks and whites of similar age and socioeconomic class. Gastroenterology. 1992;103:813–816.PubMed
24.
go back to reference Galdas PM, Cheater F, Marshall P. Men and health help-seeking behavior: literature review. J Adv Nurs. 2005;49:616–623.PubMedCrossRef Galdas PM, Cheater F, Marshall P. Men and health help-seeking behavior: literature review. J Adv Nurs. 2005;49:616–623.PubMedCrossRef
25.
go back to reference Cheatham CT, Barksdale DJ, Rogers SG. Barriers to health care and health-seeking behaviors faced by Black men. J Am Acad Nurse Pract. 2008;20:555–562.PubMedCrossRef Cheatham CT, Barksdale DJ, Rogers SG. Barriers to health care and health-seeking behaviors faced by Black men. J Am Acad Nurse Pract. 2008;20:555–562.PubMedCrossRef
Metadata
Title
African Americans with Barrett’s Esophagus Are Less Likely to Have Dysplasia at Biopsy
Authors
Joe E. Khoury
Sian Chisholm
M. Mazen Jamal
Carlos Palacio
Sunitha Pudhota
Kenneth J. Vega
Publication date
01-02-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1900-y

Other articles of this Issue 2/2012

Digestive Diseases and Sciences 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.